Hopp til hovedinnhold

Atypisk parkinsonisme

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Deutschländer AB, Ross OA, Dickson DW, Wszolek ZK.. Atypical parkinsonian syndromes: a general neurologist's perspective.. Eur J Neurol. 2017. pmid:28803444 PubMed  
  2. Schönecker S, Hell F, Bötzel K, Wlasich E, Ackl N, Süßmair C; German FTLD Consortium, Otto M, Anderl-Straub S, Ludolph A, Kassubek J, Huppertz HJ, Diehl-Schmid J, Riedl L, Roßmeier C, Fassbender K, Lyros E, Kornhuber J, Oberstein TJ, Fliessbach K, Schneider A, Schroeter ML, Prudlo J, Lauer M, Jahn H, Levin J, Danek A.The applause sign in frontotemporal lobar degeneration and related conditions. J Neurol. 2019 Feb;266(2):330-338. PMID: 30506397 PubMed  
  3. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Tröster AI, Vidailhet M, Weiner WJ.. Criteria for the diagnosis of corticobasal degeneration.. Neurology 2013; 80: 496-503. Neurology  
  4. Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, Lanza P, Barone P, Morgante L, Zappia M, Aguglia U, Gallo O.. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.. Radiology 2008; 246: 214-21. PMID:17991785 PubMed  
  5. Gröger A, Bender B, Wurster I, Chadzynski GL, Klose U, Berg D. Differentiation between idiopathic and atypical parkinsonian syndromes using three-dimensional magnetic resonance spectroscopic imaging. J Neurol Neurosurg Psychiatry. 2013; 84: 644-9. doi:10.1136/jnnp-2012-302699 DOI  
  6. Fanciulli A, Wenning GK.. Multiple-system atrophy.. N Engl J Med 2015 ; Jan 15;372(3): 249-63. Pmid: 25830435 PubMed  
  7. Chelban V, Catereniuc D, Aftene D, Gasnas A, Vichayanrat E, Iodice V, Groppa S, Houlden H. An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention. J Neurol. 2020 Sep;267(9):2754-2770. PMID: 32436100 PubMed  
  8. Miki Y1,2, Foti SC1, Asi YT1, Tsushima E3, Quinn N4, Ling H1,5, Holton JL1.. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Brain. 2019; Sep 1;142(9):: 2813-2827. pmid:31289815 PubMed  
  9. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Dürr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M. Second consensus statement on the diagnosis of multiple system atrophy.Neurology. 2008 Aug 26;71(9):670-6.PMID: 18725592 PubMed  
  10. Li M, Ma Q, Zhao X, Wang C, Wu H, Li J, Yang W. Dilemma of multiple system atrophy and spinocerebellar ataxias. J Neurol. 2018 Dec;265(12):2764-2772. PMID: 29700645 PubMed  
  11. Sullivan R, Yau WY, Chelban V, Rossi S, Dominik N, O'Connor E, Hardy J, Wood N, Cortese A, Houlden H. RFC1-related ataxia is a mimic of early multiple system atrophy. J Neurol Neurosurg Psychiatry. 2021 Feb 9;92(4):444–6. doi: 10.1136/jnnp-2020-325092. Epub ahead of print. PMID: 33563805 PubMed  
  12. Cortelli P1, Calandra-Buonaura G2, Benarroch EE2, Giannini G2, Iranzo A2, Low PA2, Martinelli P2, Provini F2, Quinn N2, Tolosa E2, Wenning GK2, Abbruzzese G2, Bower P2, Alfonsi E2, Ghorayeb I2, Ozawa T2, Pacchetti C2, Pozzi NG2, Vicini C2, Antonini A2, Bhatia KP2, Bonavita J2, Kaufmann H2, Pellecchia MT2, Pizzorni N2, Schindler A2, Tison F2, Vignatelli L2, Meissner WG2.. Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment.. Neurology. 2019; Oct 1;93(14):: 630-639. pmid:31570638 PubMed  
  13. Massey LA, Jäger HR, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton J, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Micallef C.. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.. Neurology 2013; 80: 1856-61. Neurology  
  14. Deguchi K, Ikeda K, Kume K, Takata T, Kokudo Y, Kamada M, Touge T, Honjo N, Masaki T.. Significance of the hot-cross bun sign on T2*-weighted MRI for the diagnosis of multiple system atrophy.. J Neurol. 2015. pmid: 25845765 PubMed  
  15. Pavy-Le Traon A, Piedvache A, Perez-Lloret S, Calandra-Buonaura G, Cochen-De Cock V, Colosimo C, Cortelli P, Debs R, Duerr S, Fanciulli A, Foubert-Samier A, Gerdelat A, Gurevich T, Krismer F, Poewe W, Tison F, Tranchant C, Wenning G, Rascol O, Meissner WG; European MSA Study Group.. New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study.. J Neurol Neurosurg Psychiatry 2015. pmid:25977316 PubMed  
  16. Poewe W, Seppi K, Fitzer-Attas CJ, Wenning GK, Gilman S, Low PA, Giladi N, Barone P, Sampaio C, Eyal E, Rascol O; Rasagiline-for-MSA investigators. Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial.. Lancet Neurol 2015; Feb;14(2): 145-52. pmid:25498732 PubMed  
  17. Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M . EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol 2006; 13: 930-6. PMID: 16930356 PubMed  
  18. Wieling W, Kaufmann H, Claydon VE, van Wijnen VK, Harms MPM, Juraschek SP, Thijs RD. Diagnosis and treatment of orthostatic hypotension. Lancet Neurol. 2022 Aug;21(8):735-746. doi: 10.1016/S1474-4422(22)00169-7. PMID: 35841911. PubMed  
  19. Giannini G, Provini F, Cani I, Cecere A, Mignani F, Guaraldi P, Di Mirto CVF, Cortelli P, Calandra-Buonaura G. Tracheostomy is associated with increased survival in Multiple System Atrophy patients with stridor. Eur J Neurol. 2022 Apr 6. doi: 10.1111/ene.15347. Epub ahead of print. PMID: 35384153. PubMed  
  20. Burns MR, McFarland NR. Current Management and Emerging Therapies in Multiple System Atrophy. Neurotherapeutics. 2020 Aug 6. PMID: 32767032. PubMed  
  21. Claassen DO. Multiple System Atrophy. Continuum (Minneap Minn). 2022 Oct 1;28(5):1350-1363. doi: 10.1212/CON.0000000000001154. PMID: 36222769. PubMed  
  22. Grossauer A, Sidoroff V, Heim B, Seppi K. Symptomatic Care in Multiple System Atrophy: State of the Art. Cerebellum. 2022 May 17. doi: 10.1007/s12311-022-01411-6. Epub ahead of print. PMID: 35581488. PubMed  
  23. Rowe JB, Holland N, Rittman T. Progressive supranuclear palsy: diagnosis and management. Pract Neurol. 2021 Oct;21(5):376-383. doi: 10.1136/practneurol-2020-002794. Epub 2021 Jul 2. PMID: 34215700 PubMed  
  24. Lopez G1, Bayulkem K2, Hallett M2.. Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.. Acta Neurol Scand. 2016. pmid:27070344 PubMed  
  25. Arena JE1, Weigand SD2, Whitwell JL3, Hassan A4, Eggers SD4, Höglinger GU5, Litvan I6, Josephs KA7.. Progressive supranuclear palsy: progression and survival. J Neurol. 2016; Feb;263(2): 380-9. pmid:26705121 PubMed  
  26. Couto B, Martinez-Valbuena I, Lee S, Alfradique-Dunham I, Perrin RJ, Perlmutter JS, Cruchaga C, Kim A, Visanji N, Sato C, Rogaeva E, Lang AE, Kovacs GG. Protracted course progressive supranuclear palsy. Eur J Neurol. 2022 Aug;29(8):2220-2231. doi: 10.1111/ene.15346. Epub 2022 Apr 21. PMID: 35384155. PubMed  
  27. Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I; Movement Disorder Society-endorsed PSP Study Group. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.Mov Disord. 2017 Jun;32(6):853-864. PMID: 28467028 PubMed  
  28. Wilson D et al. Corticobasal syndrome: a practical guide. Pract Neurol 2021; 21: 276-283. PubMed  
  29. Wenning GK, Krismer F, Poewe W. New insights into atypical parkinsonism. Curr Opin Neurol 2011; 24: 331-8. pmid:21577106 PubMed  
  30. Mathew R, Bak TH, Hodges JR. Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry. 2012; 83: 405-10.
  31. Di Stasio F, Suppa A, Marsili L, Upadhyay N, Asci F, Bologna M, Colosimo C, Fabbrini G, Pantano P, Berardelli A. Corticobasal syndrome: neuroimaging and neurophysiological advances. Eur J Neurol. 2019 Feb 5. PMID: 30720235 PubMed  
  32. Caixeta L, Caixeta VM, Nogueira YL, Aversi-Ferreira TA. Pharmacological interventions in corticobasal degeneration: a review. Dement Neuropsychol. 2020 Jul-Sep;14(3):243-247. PMID: 32973978 PubMed  
  33. Bluett B, Pantelyat AY, Litvan I, Ali F, Apetauerova D, Bega D, Bloom L, Bower J, Boxer AL, Dale ML, Dhall R, Duquette A, Fernandez HH, Fleisher JE, Grossman M, Howell M, Kerwin DR, Leegwater-Kim J, Lepage C, Ljubenkov PA, Mancini M, McFarland NR, Moretti P, Myrick E, Patel P, Plummer LS, Rodriguez-Porcel F, Rojas J, Sidiropoulos C, Sklerov M, Sokol LL, Tuite PJ, VandeVrede L, Wilhelm J, Wills AA, Xie T, Golbe LI. Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care. Front Neurol. 2021 Jul 1;12:694872. PMID: 34276544 PubMed  
  34. Glass PG, Lees AJ, Bacellar A, Zijlmans J, Katzenschlager R, Silveira-Moriyama L. The clinical features of pathologically confirmed vascular Parkinsonism. J Neurol Neurosurg Psychiatry 2012; 83: 1027-9.
  35. Vale TC, Caramelli P, Cardoso F. Clinicoradiological comparison between vascular parkinsonism and Parkinson's disease. J Neurol Neurosurg Psychiatry 2014. pmid:25006209 PubMed  
  36. Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, Bhatia KP, Greene PE, Przedborski S, Seal EC, Burns RS, Hauser RA, Gauger LL, Factor SA, Molho ES, Riley DE. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 1998; 55: 957-61. pmid:9678313 PubMed  
  37. Apraxia in anti-glutamic acid decarboxylase-associated stiff person syndrome: link to corticobasal degeneration?. Ann Neurol. 2015; Jan;77(1):. : 173-6. pmid: 25100431 PubMed  
  38. Schneider SA, Edwards MJ, Mir P, Cordivari C, Hooker J, Dickson J, Quinn N, Bhatia KP. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 2007 ; 22: 2210-5. pmid:17712858 PubMed  
  39. Marek K, Seibyl J, Eberly S, Oakes D, Shoulson I, Lang AE, Hyson C, Jennings D; Parkinson Study Group PRECEPT Investigators. Longitudinal follow-up of SWEDD subjects in the PRECEPT Study. Neurology 2014; 82: 1791-7. pmid:24759846 PubMed  
  40. Ling H, Kearney S, Yip HL, Silveira-Moriyama L, Revesz T, Holton JL, Strand C, Davey K, Mok KY, Polke JM, Lees AJ. Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?. J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):633-41 . pmid:26209716 PubMed  
  41. Erro R, Schneider SA, Stamelou M, Quinn NP, Bhatia KP.. What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.. J Neurol Neurosurg Psychiatry 2015. pmid: 25991401 PubMed  
  42. Aerts MB, Esselink RA, Post B, van de Warrenburg BP, Bloem BR. Improving the diagnostic accuracy in parkinsonism: a three-pronged approach. Pract Neurol. 2012; 12: 77-87. pmid:22450452 PubMed  
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Åse Mygland, spesialist i nevrologi, professor dr med
  • Kenn Freddy Pedersen, spesialist i nevrologi, PhD
  • Guido Alves, spesialist i nevrologi, professor, PhD